Corey S Goodman

Biography

Corey is a managing partner at venBio and has spent most of the last 15 years in Pharma and Biotech. He is currently Chairman of Oligasis, Solstice, Second Genome and Labrys Biologics. In 2007 he joined Pfizer as President and Founder of the Biotherapeutics and Bioinnovation Center, a new division focusing on Biologics and was a member of Pfizer’s Executive Leadership Team reporting to the CEO. He designed and built a new entrepreneurial R&D model with a focus on discovering and developing new therapeutics for unmet medical needs, and fostering innovation and game-changing technology. Corey founded two companies Exelixis and Renovis and led Renovis as President and CEO from a private to public company until its acquisition by Evotec. He obtained a BS from Stanford University and a PhD from UC Berkeley and spent 25 years as Professor of Neurobiology at Stanford. He became the Evan Rauch chair at UC Berkeley where he was a Howard Hughes Investigator and co-founder and director of the Wills Neuroscience Institute. He is the author of over 200 scientific papers. Corey is a member of the National Academy of Sciences and the American Philosophical Society. He has received many honours including the Alan T. Waterman award, the Canadian Gairdner Biomedical Award, the March of Dimes Prize and the Reeve-Irvine Research Medal.  

Research Interest

 Business Management